NANEXA.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 10:53):

Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition...

Stats
Today's Volume	285 316
Average Volume	411 772
Market Cap	89.83M
EPS	SEK0 ( 2024-02-20 )
Next earnings date	( SEK0 ) 2024-05-02
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.610
ATR14	SEK0.00500 (0.76%)

Volume Correlation

Long: -0.17 (neutral)

Short: -0.31 (neutral)

Signal:(68.8) Neutral

Nanexa AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanexa AB (publ) Correlation - Currency/Commodity

-0.25
( neutral )

-0.19
( neutral )

0.00
( neutral )

0.16
( neutral )

Nanexa AB (publ) Financials

Annual	2023
Revenue:	SEK29.33M
Gross Profit:	SEK-21.90M (-74.66 %)
EPS:	SEK-1.090

Q4	2023
Revenue:	SEK6.82M
Gross Profit:	SEK-51.26M (-752.11 %)
EPS:	SEK-0.520

Q3	2023
Revenue:	SEK6.68M
Gross Profit:	SEK13.75M (205.67 %)
EPS:	SEK-0.110

Q2	2023
Revenue:	SEK7.66M
Gross Profit:	SEK17.07M (223.03 %)
EPS:	SEK-0.160

Financial Reports:

No articles found.

Nanexa AB (publ)

Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.